GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calithera Biosciences Inc (STU:2CB0) » Definitions » Shiller PE Ratio

Calithera Biosciences (STU:2CB0) Shiller PE Ratio : (As of May. 12, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Calithera Biosciences Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Calithera Biosciences Shiller PE Ratio Historical Data

The historical data trend for Calithera Biosciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calithera Biosciences Shiller PE Ratio Chart

Calithera Biosciences Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Calithera Biosciences Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Calithera Biosciences's Shiller PE Ratio

For the Biotechnology subindustry, Calithera Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Calithera Biosciences's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Calithera Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Calithera Biosciences's Shiller PE Ratio falls into.



Calithera Biosciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Calithera Biosciences's E10 for the quarter that ended in Dec. 2022 is calculated as:

For example, Calithera Biosciences's adjusted earnings per share data for the three months ended in Dec. 2022 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2022 (Change)*Current CPI (Dec. 2022)
=0/125.2218*125.2218
=0.000

Current CPI (Dec. 2022) = 125.2218.

Calithera Biosciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201212 0.000 96.871 0.000
201306 0.000 98.518 0.000
201309 -6.288 98.790 -7.970
201312 -7.559 98.326 -9.627
201403 -7.600 99.695 -9.546
201406 -5.089 100.560 -6.337
201409 -5.120 100.428 -6.384
201412 -6.177 99.070 -7.808
201503 -8.131 99.621 -10.221
201506 -7.841 100.684 -9.752
201509 -8.732 100.392 -10.892
201512 -8.078 99.792 -10.136
201603 -9.339 100.470 -11.640
201606 -9.790 101.688 -12.056
201609 -7.841 101.861 -9.639
201612 -8.532 101.863 -10.489
201703 -4.114 102.862 -5.008
201706 -2.670 103.349 -3.235
201709 -2.853 104.136 -3.431
201712 -5.239 104.011 -6.307
201803 -6.001 105.290 -7.137
201806 -1.541 106.317 -1.815
201809 -8.913 106.507 -10.479
201812 -8.966 105.998 -10.592
201903 -10.797 107.251 -12.606
201906 -10.266 108.070 -11.895
201909 -6.901 108.329 -7.977
201912 -7.020 108.420 -8.108
202003 -6.878 108.902 -7.909
202006 -5.150 108.767 -5.929
202009 -5.434 109.815 -6.196
202012 -5.261 109.897 -5.995
202103 -4.704 111.754 -5.271
202106 -3.204 114.631 -3.500
202109 -2.559 115.734 -2.769
202112 -16.284 117.630 -17.335
202203 -3.269 121.301 -3.375
202206 -1.504 125.017 -1.506
202209 -2.030 125.227 -2.030
202212 0.000 125.222 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Calithera Biosciences  (STU:2CB0) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Calithera Biosciences Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Calithera Biosciences's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Calithera Biosciences (STU:2CB0) Business Description

Traded in Other Exchanges
N/A
Address
343 Oyster Point Boulevard, Suite 200, South San Francisco, CA, USA, 94080
Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm functions through the region of the United States. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications.

Calithera Biosciences (STU:2CB0) Headlines

No Headlines